Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey

Showing results (171-180 of 17,179) with videos related to

Pageof 1,718
Sort By:
American Family Physician|May 3, 2014
Gabapentin for the prophylaxis of episodic migraine in adultsCorey D Fogleman
JAMA Neurology|November 2, 2016
Doubts About Therapy for Neurological Diseases With Antisense Oligonucleotides-ReplyDavid R Corey
ACS Chemical Neuroscience|October 2, 2012
ACS chemical neuroscience molecule spotlight on SuvorexantCorey R Hopkins
ACS Chemical Neuroscience|August 4, 2012
ACS chemical neuroscience molecule spotlight on Begacestat (GSI-953)Corey R Hopkins
ACS Chemical Neuroscience|August 4, 2012
ACS chemical neuroscience molecule spotlight on BMS-708163Corey R Hopkins
ACS Chemical Neuroscience|July 11, 2012
ACS chemical neuroscience molecule spotlight on ValdoxenCorey R Hopkins
ACS Chemical Neuroscience|July 11, 2012
ACS chemical neuroscience molecule spotlight on SabrilCorey R Hopkins
ACS Chemical Neuroscience|July 11, 2012
ACS chemical neuroscience molecule spotlight on ELND006: another γ-secretase inhibitor fails in the clinicCorey R Hopkins
Nucleic Acid Therapeutics|November 21, 2024
It is Time to Revisit miRNA TherapeuticsDavid R Corey
Nature Reviews. Neurology|April 16, 2016
Neurodegenerative disease: MRI biomarkers - a precision medicine tool in neurology?Corey T McMillan
Pageof 1,718

Showing results (171-180 of 17,179) with videos related to

Sort By:
Pageof 1,718
American Family Physician|May 3, 2014
Gabapentin for the prophylaxis of episodic migraine in adultsCorey D Fogleman
JAMA Neurology|November 2, 2016
Doubts About Therapy for Neurological Diseases With Antisense Oligonucleotides-ReplyDavid R Corey
ACS Chemical Neuroscience|October 2, 2012
ACS chemical neuroscience molecule spotlight on SuvorexantCorey R Hopkins
ACS Chemical Neuroscience|August 4, 2012
ACS chemical neuroscience molecule spotlight on Begacestat (GSI-953)Corey R Hopkins
ACS Chemical Neuroscience|August 4, 2012
ACS chemical neuroscience molecule spotlight on BMS-708163Corey R Hopkins
ACS Chemical Neuroscience|July 11, 2012
ACS chemical neuroscience molecule spotlight on ValdoxenCorey R Hopkins
ACS Chemical Neuroscience|July 11, 2012
ACS chemical neuroscience molecule spotlight on SabrilCorey R Hopkins
ACS Chemical Neuroscience|July 11, 2012
ACS chemical neuroscience molecule spotlight on ELND006: another γ-secretase inhibitor fails in the clinicCorey R Hopkins
Nucleic Acid Therapeutics|November 21, 2024
It is Time to Revisit miRNA TherapeuticsDavid R Corey
Nature Reviews. Neurology|April 16, 2016
Neurodegenerative disease: MRI biomarkers - a precision medicine tool in neurology?Corey T McMillan
Pageof 1,718